Skip to main content
Clinical Trials/NCT02255721
NCT02255721
Unknown
N/A

Healthy Sleep Intervention For Preschool Children: A Randomized Controlled Trial of the SHIP Intervention

Seattle Children's Hospital1 site in 1 country500 target enrollmentNovember 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Sleep Initiation and Maintenance Disorders
Sponsor
Seattle Children's Hospital
Enrollment
500
Locations
1
Primary Endpoint
Change in actigraphic and diary measured sleep quantity and quality measures
Last Updated
5 years ago

Overview

Brief Summary

The SHIP study is a randomized controlled trial of an intervention for preschool children with sleep problems, in which we aim to give parents the knowledge, motivation, and skills necessary to set goals, problem-solve, and improve their child's sleep. In collecting three years of follow-up data, we will be able to determine the impact of the SHIP intervention on childhood sleep problems, obesity, academic achievement, and emotional and behavioral problems, as well as parental stress and daytime tiredness. This study has the dual potential to expand treatment resources for young children with behavioral sleep problems and to increase our scientific understanding of the long-term consequences of early childhood sleep problems.

Registry
clinicaltrials.gov
Start Date
November 2013
End Date
December 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michelle Garrison

Research Assistant Professor, University of Washington

Seattle Children's Hospital

Eligibility Criteria

Inclusion Criteria

  • Age 30-71 months
  • Child behavioral sleep problem, as demonstrated by a score on the Children's Sleep Habits Questionnaire (CSHQ) of at least 50, or a score of 41-49 and reported weeknight sleep of 9hrs or less per night
  • English speaking parent or guardian

Exclusion Criteria

  • Sleep disordered breathing, as demonstrated by a score on the CSHQ of at least 5
  • Currently taking prescribed sleep medications, psychostimulants, and/or systemic corticosteroids
  • Serious medical conditions likely to affect sleep, including diabetes or cancer
  • Major cognitive or developmental disorder, including autism spectrum disorder

Outcomes

Primary Outcomes

Change in actigraphic and diary measured sleep quantity and quality measures

Time Frame: Baseline, 36-month follow-up

Change in actigraphic and diary measured sleep quantity (total sleep time, nocturnal sleep time) and quality (percent wake after sleep onset) measures

Change in actigraphic and parent report measures of sleep onset difficulties

Time Frame: Baseline, 36-month follow-up

Change in actigraphic and parent report measures of sleep onset difficulties (sleep onset latency, Child Sleep Wake Scale subscales for Going to Bed and Falling Asleep)

Secondary Outcomes

  • Change in child anthropometric measures(Baseline, 36-month follow-up)
  • Trajectory in child anthropometric measures(Baseline, 12-month follow-up, 24-month follow-up, 36-month follow-up)
  • Change in parent-reported child behavioral and emotional symptoms and executive function(Baseline, 12-month follow-up)
  • Change in parent & teacher-reported child behavioral and emotional symptoms and executive function(Baseline, 36-month follow-up)
  • Change in parent & teacher-reported child behavioral and emotional symptoms (CBCL subscores for anxious/depressed, attention, somatic complaints, and aggressive behavior) and executive function (BRIEF subscores for inhibit, shift, and emotional control)(Baseline, 24-month follow-up)
  • Change in directly assessed performance on WJIII NU achievement battery and executive function(Baseline, 36-month follow-up)
  • Trajectory in actigraphic and diary measured sleep quantity and quality measures(Baseline, 3-month follow-up, 12-month follow-up, 24-month follow-up, 36-month follow-up)
  • Trajectory in actigraphic and parent report measures of sleep onset difficulties(Baseline, 3-month follow-up, 12-month follow-up, 24-month follow-up, 36-month follow-up)

Study Sites (1)

Loading locations...

Similar Trials